期刊中心

Vaccine
(Vaccine) 《疫苗》

网友评分
疫苗
2015年影响因子
3.413
期刊介绍

《疫苗》杂志是爱德华·詹纳学会、国际疫苗学会和日本疫苗学会的官方刊物。主要接受以下方面的投稿:人用疫苗-感染性疾病,人用疫苗-非感染性疾病,兽用疫苗,免疫学与动物模型,载体、佐剂和投药系统,生产与制造,疫苗安全性,监管、社会及法规事项,疫苗学历史。

展开
推荐阅读
目录导读
Published 2012年10月,Volume 30,Issue 47

最新一期


Page CO2
Editorial
2You are not entitled to access the full text of this document

Nanovaccinology: The next generation of vaccines meets 21st century materials science and engineering


Pages 6609-6611
Tewodros Mamo, Gregory A. Poland
Purchase $31.50
Meeting report
3You are not entitled to access the full text of this document

Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16–17 November 2011


Pages 6612-6622
Bethan Hughes, Frederick Hayden, Yuri Perikov, Joachim Hombach, John S. Tam
Purchase $31.50
Brief reports
4You are not entitled to access the full text of this document

Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China


Pages 6623-6627
Liping Shen, Fuzhen Wang, Feng Wang, Fuqiang Cui, Shuang Zhang, Hui Zheng, Yong Zhang, Xiaofeng Liang, Shengli Bi
Purchase $31.50
5You are not entitled to access the full text of this document

HLA-DR specific monoclonal antibodies block lymphoproliferative response to measles vaccine in vitro: A pilot study


Pages 6628-6631
David M. Phelan, Gregory A. Poland
Purchase $31.50
Regular papers
6You are not entitled to access the full text of this document

Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel

 Original Research Article
Pages 6632-6635
Yael Levy, Emilia Anis, Ehud Kaliner, Itamar Grotto, Yehuda L. Danon
Purchase $31.50

Highlights

► The bioterror threat has prompted formulation of national preparedness strategies. ► We estimated the population at risk of adverse events of smallpox vaccine in Israel. ► The databases of the Israel Ministry of Health and the largest HMO were searched. ► This special population accounted for 4.3% of the national population. ► This information is essential for effective mass-vaccination programs.
7You are not entitled to access the full text of this document

Safety of Zostavax™—A cohort study in a managed care organization

 Original Research Article
Pages 6636-6641
Roger Baxter, Trung Nam Tran, John Hansen, Michael Emery, Bruce Fireman, Joan Bartlett, Ned Lewis, Patricia Saddier
Purchase $31.50

Highlights

► This was an analysis of safety of the zoster vaccine. ► Risk-interval cohort study. ► 29,000 persons who received the zoster vaccine in 2006 and 2007. ► No clear increase in events was observed in the risk period after vaccination compared to later. ► People received zoster vaccine when their health was optimal, which led to confounding.
8You are not entitled to access the full text of this document

A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge

 Original Research Article
Pages 6642-6648
Qingwei Liu, Kexia Yan, Yanfang Feng, Xulin Huang, Zhiqiang Ku, Yicun Cai, Fei Liu, Jinping Shi, Zhong Huang
Purchase $31.50

Highlights

► Virus-like particle (VLP) of coxsackievirus A16 was successfully produced. ► VLP immunization potently elicited neutralizing antibodies in mice. ► Passive transfer of anti-VLP sera protected mice against CVA16 lethal infection.
9You are not entitled to access the full text of this document

Effect of the vaccination scheme on PregSure®BVD induced alloreactivity and the incidence ofBovine Neonatal Pancytopenia

 Original Research Article
Pages 6649-6655
Rahel Kasonta, Carola Sauter-Louis, Mark Holsteg, Karin Duchow, Klaus Cussler, Max Bastian
Purchase $31.50

Highlights

► Regional differences in the incidence of Bovine Neonatal Pancytopenia (BNP) are identified. ► The differences correlate with variations in the BVD-vaccination regimen. ► The causal correlation is confirmed by experimental immunization.
10You are not entitled to access the full text of this document

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age

 Original Research Article
Pages 6656-6664
Gustavo H. Dayan, Joan Bevilacqua, Dorothy Coleman, Aileen Buldo, George Risi
Purchase $31.50

Highlights

► ChimeriVax-WN02 is a live attenuated vaccine for protection against West Nile virus. ► We assessed the immunogenicity and safety of ChimeriVax-WN02 in subjects aged ≥50. ► Subjects were randomized in 3 groups to receive 1 dose of a different formulation. ► Seroconversion was achieved at day 28 by >92% of subjects in each of the groups. ► ChimeriVax-WN02 was well tolerated in subjects in all groups.
11You are not entitled to access the full text of this document

Probing the protective effects of a conformationally constrained nicotine vaccine

Original Research Article
Pages 6665-6670
Amira Y. Moreno, Marc R. Azar, George F. Koob, Kim D. Janda
Purchase $31.50

Highlights

► Constrained and unconstrained nicotine haptens generate differential immune responses. ► Vaccination of constrained hapten CNI with ALUM showed protective effects in rats. ► High antibody concentration was found to be crucial in conferring protective effects. ► Nicotine analgesia is a rapid assay to probe vaccination effects.
12You are not entitled to access the full text of this document

Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions

 Original Research Article
Pages 6671-6677
Hwi Won Seo, Kiwon Han, Yeonsu Oh, Changhoon Park, Chanhee Chae
Purchase $31.50

Highlights

► Chimeric PCV1-2 vaccine seems to be very effective in controlling PCV2 infection. ► Vaccinated animals displayed an improved ADG and a reduced time to market. ► Vaccination induced strong neutralizing antibodies and PCV2-specific IFN-r-SC. ► Vaccination can elicit PCV2-specific NA and IFN-γ-SC even in the presence of MDA.
13You are not entitled to access the full text of this document

Protective immunity against tick infestation in cattle vaccinated with recombinant trypsin inhibitor of Rhipicephalus microplus

 Original Research Article
Pages 6678-6685
Renato Andreotti, Rodrigo Casquero Cunha, Mariana Aparecida Soares, Felix D. Guerrero, Fábio P. Leivas Leite, Adalberto A. Pérez de León
Purchase $31.50

Highlights

► Tested vaccine with recombinant Kunitz protein for cattle tick immunoprotection. ► Larval Rmicroplus trypsin inhibitor was produced in yeast expression system. ► Immunization afforded 32% efficacy against cattle tick infestation. ► Larval Rmicroplustrypsin inhibitor resembles three-headed Kunitz protein BmTI-6.
14You are not entitled to access the full text of this document

Seroprevalence of seven high-risk HPV types in The Netherlands

 Original Research Article
Pages 6686-6693
Mirte Scherpenisse, Madelief Mollers, Rutger M. Schepp, Hein J. Boot, Hester E. de Melker, Chris J.L.M. Meijer, Guy A.M. Berbers, Fiona R.M. van der Klis
Purchase $31.50

Highlights

► Pre-HPV vaccine antibody levels serve as baseline to evaluate long-term HPV vaccination effects. ► The increase in HPV seroprevalence in adolescents correlates with sexual debut, mainly for HPV16 in women. ► 10% of the population was found seropositive for multiple HPV serotypes. ► Ethnicity, marital status, casual partnership or having a STD increased the risk of HPV seropositivity.
15You are not entitled to access the full text of this document

No effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural experiment

 Original Research Article
Pages 6694-6699
Najaaraq Lund, Andreas Andersen, Ivan Monteiro, Peter Aaby, Christine Stabell Benn
Purchase $31.50

Highlights

► This study did not support that OPV0 is associated with increased mortality in boys. ► If anything, mortality tended to be higher in infants who did not receive OPV0. ► OPV administered with BCG may lead to a dampened immune response to BCG.
16You are not entitled to access the full text of this document

Distinguishing vaccine efficacy and effectiveness

 Original Research Article
Pages 6700-6705
Eunha Shim, Alison P. Galvani
Purchase $31.50

Highlights

► There are two mechanisms of vaccine action, ‘all-or-nothing’ and ‘leaky’ vaccines. ► Typical estimation of ‘leaky’ vaccine efficacy has been incorrect in mathematical models. ► We demonstrate how the common measures of vaccine can be correctly estimated.
17You are not entitled to access the full text of this document

Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development

 Original Research Article
Pages 6706-6712
Jennifer L. Peters, Paul L. DeMars, Lindsay M. Collins, Julie A. Stoner, Hiroyuki Matsumoto, Naoka Komori, Anil Singh, Christa L. Feasley, James A. Haddock, Martin Levine
Purchase $31.50

Highlights

► Lysine is required to maintain an epithelial barrier to bacteria in gingival sulci. ► Lysine decarboxylase from Eikenella corrodensdepletes lysine from gingival sulci. ► Antibodies to lysine decarboxylase slow lysine depletion and gingivitis progression. ► Lysine decarboxylase vaccination may retard canine periodontal disease progression.
18You are not entitled to access the full text of this document

US Military contributions to the global response to pandemic chikungunya

 Original Research Article
Pages 6713-6720
Charles H. Hoke Jr., Judy Pace-Templeton, Phillip Pittman, Frank J. Malinoski, Paul Gibbs, Tracy Ulderich, Michelle Mathers, Beverly Fogtman, Pamela Glass, David W. Vaughn
Purchase $31.50
19You are not entitled to access the full text of this document

Waning population immunity to measles in Taiwan

 Original Research Article
Pages 6721-6727
Chih-Jung Chen, Ping-Ing Lee, Yu-Chia Hsieh, Po-Yen Chen, Yu-Huai Ho, Chee-Jen Chang, Ding-Ping Liu, Feng-Yee Chang, Cheng-Hsun Chiu, Yhu-Chering Huang, Chin-Yun Lee, Tzou-Yien Lin
Purchase $31.50

Highlights

► The coverage rate of measles vaccine was >95% for more than a decade in Taiwan. ► We estimated the seroprevalence of measles in Taiwan using volunteer-based samples. ► There was a significant declining trend of seropositivity with age in vaccinees. ► The overall seroprevalence of measles was not sufficient for herd immunity. ► Waning vaccine-induced immunity weakened the population immunity to measles.
Book review
20You are not entitled to access the full text of this document

H. Bazin, ,Vaccination: A History. From Lady Montagu to Genetic Engineering (2011) John Libbey Eurotext,UK.


Page 6728
Andrew W. Artenstein
发表评论网友评论(0)

审稿周期: 投稿难度:
发表评论